retatrutide approval fda 2025 Promises Big Weight Loss, but Safety Remains a Question retatrutide side effects clinical trials

One exception is the class of glucagon-like peptide-1 receptor (GLP-1R) agonists, which can be used to treat not only type 2 diabetes but obesity, hyperphagia, and hypertension 5,6,7

Follow these steps exactly for optimal results

The side effects are generally the same, as the medications work the same way for both conditions

After menopause, fat shifts to the abdomen, particularly the visceral compartment surrounding the organs

Because people often ask how allulose stacks up against other sweeteners in terms of fermentation and gut effects, I put together a separate guide that explains how different sweeteners behave in the digestive tract